ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,047 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 101-125 of 1,000 matching filings.

Per page
25
Current page
5
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
02 Feb 2026
Reporting date
02 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI RECOMMENDED IN EU FOR EARLY GASTRIC CANCER

Filing date
02 Feb 2026
Reporting date
02 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA BEGINS TRADING ON NYSE

Filing date
02 Feb 2026
Reporting date
02 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
25 File 001-11960

FORM 25

Filing date
30 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA AGREES OBESITY AND T2D DEAL WITH CSPC

Filing date
30 Jan 2026
Reporting date
30 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA INVESTS $15BN IN CHINA THROUGH 2030

Filing date
29 Jan 2026
Reporting date
29 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-11960

NYSE CERTIFICATION

Filing date
22 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-11960

8-A12B

Filing date
22 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-11960

NYSE CERTIFICATION

Filing date
22 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-11960

8-A12B

Filing date
22 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA TO COMPLETE DIRECT LISTING ON NYSE

Filing date
20 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

AZN NEW HEAD OF INVESTOR RELATIONS JORIS SILON

Filing date
08 Jan 2026
Reporting date
08 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
02 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
22 Dec 2025
Reporting date
22 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU GRANTED BTD FOR POST-NEOADJUVANT EARLY BC

Filing date
22 Dec 2025
Reporting date
22 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

UPDATE ON LATIFY PHASE III TRIAL OF CERALASERTIB

Filing date
22 Dec 2025
Reporting date
22 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
19 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

SUBCUTANEOUS SAPHNELO APPROVED IN EU

Filing date
16 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU APPROVED IN US FOR 1L HER2+ METASTATIC BC

Filing date
16 Dec 2025
Reporting date
16 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

HOLDING(S) IN COMPANY

Filing date
04 Dec 2025
Reporting date
04 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

BLOCK LISTING INTERIM REVIEW

Filing date
01 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI APPROVED IN US FOR EARLY GASTRIC CANCER

Filing date
26 Nov 2025
Reporting date
26 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA MANUFACTURING INVESTMENT IN MARYLAND

Filing date
24 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

KOSELUGO (SELUMETINIB) APPROVED IN THE US

Filing date
20 Nov 2025
Reporting date
20 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .